| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Coeptis Therapeutics Holdings, Inc. | Director | Common Stock | 8,950 | $128,701 | $14.38 | 11 Feb 2026 | Direct |
| Coeptis Therapeutics Holdings, Inc. | Director | Non-qualified Stock Options (right to buy) | 8,950 | 04 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| COEP | Coeptis Therapeutics Holdings, Inc. | 11 Feb 2026 | 2 | +$60,192 | 4 | Director | 13 Feb 2026, 17:00 |
| COEP | Coeptis Therapeutics Holdings, Inc. | 04 Mar 2025 | 1 | $0 | 4 | Director | 10 Mar 2025, 21:23 |
| COEP | Coeptis Therapeutics Holdings, Inc. | 27 Jan 2023 | 1 | $0 | 4 | Director | 31 Jan 2023, 09:53 |
| COEP | Coeptis Therapeutics Holdings, Inc. | 28 Oct 2022 | 0 | $0 | 3 | Director | 07 Nov 2022, 12:56 |